Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential

Objectives. The aim of our study was to determine the important molecules responsible for the invasive activity of ovarian cancer cells. Methods. We compared the biological characteristics, that is, growth rate, motility, and invasive activity, of five ovarian cancer cell lines with the gene express...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecologic oncology 2000-11, Vol.79 (2), p.256-263
Hauptverfasser: Nishikawa, Akira, Iwasaki, Masahiro, Akutagawa, Noriyuki, Manase, Kengo, Yamashita, Satoko, Endo, Toshiaki, Kudo, Ryuichi
Format: Artikel
Sprache:eng
Schlagworte:
Ets
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 263
container_issue 2
container_start_page 256
container_title Gynecologic oncology
container_volume 79
creator Nishikawa, Akira
Iwasaki, Masahiro
Akutagawa, Noriyuki
Manase, Kengo
Yamashita, Satoko
Endo, Toshiaki
Kudo, Ryuichi
description Objectives. The aim of our study was to determine the important molecules responsible for the invasive activity of ovarian cancer cells. Methods. We compared the biological characteristics, that is, growth rate, motility, and invasive activity, of five ovarian cancer cell lines with the gene expression of various matrix proteases (matrix metalloproteinase-1 [MMP-1], MMP-2, MMP-9, membrane-type MMP type 1 [MT1-MMP], MT2-MMP, MT3-MMP, urokinase plasminogen activator [uPA]), their inhibitors (tissue inhibitor of metalloproteinase type 1 [TIMP-1], TIMP-2, plasminogen activator inhibitor type 1, [PAI-1], and PAI-2), and the potential transcriptional regulators E1AF and Ets-1. Results. There was no clear correlation in the growth rate, motility, and invasion, suggesting that there are independent properties for malignant potential in ovarian cancer cells. However, HTBOA, a poorly differentiated cancer cell line, exhibited highly invasive activity, rapid growth, and increased motility. This cell line also expressed both Ets transcriptional factors, E1AF and Ets-1, and many matrix-degrading enzymes. Three cell lines that expressed E1AF showed rapid cell growth. The highly invasive cell lines, HTBOA and HTOA (well-differentiated serous cystadenocarcinoma), produced either MMP-2 or MMP-1, and both cell lines expressed MT1-MMP and uPA. Furthermore, the active forms of pro-MMP-2 and pro-MMP-1 were detected in HTBOA and HTOA by zymography. Conclusion. We conclude that activated MMP-2 and MMP-1 are important in the invasive activity of these ovarian cancer cells.
doi_str_mv 10.1006/gyno.2000.5944
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72394001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090825800959444</els_id><sourcerecordid>72394001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-ce91af050b9aa56e2129c6d60edce4d74fbbe26228cd03bed032734c74f2edcf3</originalsourceid><addsrcrecordid>eNp1kcFv0zAUxi0EYmXjyhFZQtotxXYSN-GGog4mddoOY1frxXlBRqld_Nxq_SP4n3HUCk672JL9-z4_fx9jH6RYSiH0559HH5ZKCLGs26p6xRZStHWhm7p9zRZCtKJoVN1csHdEvzJVCqnesgsphS51XS3Yn_XzLiKRC56HkT9BdGFP_A5SdM_8IYaEQEgc_MDXifgNbN105I8RPNnodikLYcrHNoVI3Hl-f8ge4HkH3mLkHU4T3ziP9IV3IUacYNbwFPitPwC5A_KH_IpPDqYr9maEifD9eb9kP27Wj933YnP_7bb7uilspctUWGwljKIWfQtQa1RStVYPWuBgsRpW1dj3qLRSjR1E2WNe1KqsbL5QGRnLS3Z98t3F8HuPlMzWkc2Tgsf8fbNSZVsJITO4PIE2BqKIo9lFt4V4NFKYuQAzF2DmAsxcQBZ8PDvv-y0O__Fz4hn4dAaALExjDtI6-setWl2pMlPNicKcwsFhNGQd5kAHF9EmMwT30gR_AYBbpIw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72394001</pqid></control><display><type>article</type><title>Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Nishikawa, Akira ; Iwasaki, Masahiro ; Akutagawa, Noriyuki ; Manase, Kengo ; Yamashita, Satoko ; Endo, Toshiaki ; Kudo, Ryuichi</creator><creatorcontrib>Nishikawa, Akira ; Iwasaki, Masahiro ; Akutagawa, Noriyuki ; Manase, Kengo ; Yamashita, Satoko ; Endo, Toshiaki ; Kudo, Ryuichi</creatorcontrib><description>Objectives. The aim of our study was to determine the important molecules responsible for the invasive activity of ovarian cancer cells. Methods. We compared the biological characteristics, that is, growth rate, motility, and invasive activity, of five ovarian cancer cell lines with the gene expression of various matrix proteases (matrix metalloproteinase-1 [MMP-1], MMP-2, MMP-9, membrane-type MMP type 1 [MT1-MMP], MT2-MMP, MT3-MMP, urokinase plasminogen activator [uPA]), their inhibitors (tissue inhibitor of metalloproteinase type 1 [TIMP-1], TIMP-2, plasminogen activator inhibitor type 1, [PAI-1], and PAI-2), and the potential transcriptional regulators E1AF and Ets-1. Results. There was no clear correlation in the growth rate, motility, and invasion, suggesting that there are independent properties for malignant potential in ovarian cancer cells. However, HTBOA, a poorly differentiated cancer cell line, exhibited highly invasive activity, rapid growth, and increased motility. This cell line also expressed both Ets transcriptional factors, E1AF and Ets-1, and many matrix-degrading enzymes. Three cell lines that expressed E1AF showed rapid cell growth. The highly invasive cell lines, HTBOA and HTOA (well-differentiated serous cystadenocarcinoma), produced either MMP-2 or MMP-1, and both cell lines expressed MT1-MMP and uPA. Furthermore, the active forms of pro-MMP-2 and pro-MMP-1 were detected in HTBOA and HTOA by zymography. Conclusion. We conclude that activated MMP-2 and MMP-1 are important in the invasive activity of these ovarian cancer cells.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1006/gyno.2000.5944</identifier><identifier>PMID: 11063654</identifier><identifier>CODEN: GYNOA3</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Adenocarcinoma - genetics ; Adenocarcinoma - metabolism ; Adenocarcinoma - pathology ; Adenovirus E1A Proteins - biosynthesis ; Adenovirus E1A Proteins - genetics ; Biological and medical sciences ; Carcinoma, Endometrioid - enzymology ; Carcinoma, Endometrioid - genetics ; Carcinoma, Endometrioid - pathology ; Cell Division - physiology ; Cell Movement - physiology ; Cystadenocarcinoma, Serous - genetics ; Cystadenocarcinoma, Serous - metabolism ; Cystadenocarcinoma, Serous - pathology ; E1AF ; Enzyme Activation ; Enzyme Precursors - metabolism ; Ets ; Female ; Female genital diseases ; Gene Expression ; Gynecology. Andrology. Obstetrics ; Humans ; invasion ; Matrix Metalloproteinases - biosynthesis ; Matrix Metalloproteinases - genetics ; Matrix Metalloproteinases - metabolism ; matrix protease ; Medical sciences ; motility ; Neoplasm Invasiveness ; ovarian cancer ; Ovarian Neoplasms - enzymology ; Ovarian Neoplasms - metabolism ; Ovarian Neoplasms - pathology ; Plasminogen Activator Inhibitor 1 - biosynthesis ; Plasminogen Activator Inhibitor 1 - genetics ; Plasminogen Activator Inhibitor 2 - biosynthesis ; Plasminogen Activator Inhibitor 2 - genetics ; Proto-Oncogene Protein c-ets-1 ; Proto-Oncogene Proteins - biosynthesis ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins c-ets ; RNA, Messenger - biosynthesis ; RNA, Messenger - genetics ; Tissue Inhibitor of Metalloproteinase-1 - biosynthesis ; Tissue Inhibitor of Metalloproteinase-1 - genetics ; Tissue Inhibitor of Metalloproteinase-2 - biosynthesis ; Tissue Inhibitor of Metalloproteinase-2 - genetics ; Transcription Factors - biosynthesis ; Transcription Factors - genetics ; Tumor Cells, Cultured ; Tumors ; Urokinase-Type Plasminogen Activator - biosynthesis ; Urokinase-Type Plasminogen Activator - genetics ; Urokinase-Type Plasminogen Activator - metabolism</subject><ispartof>Gynecologic oncology, 2000-11, Vol.79 (2), p.256-263</ispartof><rights>2000 Academic Press</rights><rights>2001 INIST-CNRS</rights><rights>Copyright 2000 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-ce91af050b9aa56e2129c6d60edce4d74fbbe26228cd03bed032734c74f2edcf3</citedby><cites>FETCH-LOGICAL-c463t-ce91af050b9aa56e2129c6d60edce4d74fbbe26228cd03bed032734c74f2edcf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/gyno.2000.5944$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=796423$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11063654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nishikawa, Akira</creatorcontrib><creatorcontrib>Iwasaki, Masahiro</creatorcontrib><creatorcontrib>Akutagawa, Noriyuki</creatorcontrib><creatorcontrib>Manase, Kengo</creatorcontrib><creatorcontrib>Yamashita, Satoko</creatorcontrib><creatorcontrib>Endo, Toshiaki</creatorcontrib><creatorcontrib>Kudo, Ryuichi</creatorcontrib><title>Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>Objectives. The aim of our study was to determine the important molecules responsible for the invasive activity of ovarian cancer cells. Methods. We compared the biological characteristics, that is, growth rate, motility, and invasive activity, of five ovarian cancer cell lines with the gene expression of various matrix proteases (matrix metalloproteinase-1 [MMP-1], MMP-2, MMP-9, membrane-type MMP type 1 [MT1-MMP], MT2-MMP, MT3-MMP, urokinase plasminogen activator [uPA]), their inhibitors (tissue inhibitor of metalloproteinase type 1 [TIMP-1], TIMP-2, plasminogen activator inhibitor type 1, [PAI-1], and PAI-2), and the potential transcriptional regulators E1AF and Ets-1. Results. There was no clear correlation in the growth rate, motility, and invasion, suggesting that there are independent properties for malignant potential in ovarian cancer cells. However, HTBOA, a poorly differentiated cancer cell line, exhibited highly invasive activity, rapid growth, and increased motility. This cell line also expressed both Ets transcriptional factors, E1AF and Ets-1, and many matrix-degrading enzymes. Three cell lines that expressed E1AF showed rapid cell growth. The highly invasive cell lines, HTBOA and HTOA (well-differentiated serous cystadenocarcinoma), produced either MMP-2 or MMP-1, and both cell lines expressed MT1-MMP and uPA. Furthermore, the active forms of pro-MMP-2 and pro-MMP-1 were detected in HTBOA and HTOA by zymography. Conclusion. We conclude that activated MMP-2 and MMP-1 are important in the invasive activity of these ovarian cancer cells.</description><subject>Adenocarcinoma - genetics</subject><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenovirus E1A Proteins - biosynthesis</subject><subject>Adenovirus E1A Proteins - genetics</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Endometrioid - enzymology</subject><subject>Carcinoma, Endometrioid - genetics</subject><subject>Carcinoma, Endometrioid - pathology</subject><subject>Cell Division - physiology</subject><subject>Cell Movement - physiology</subject><subject>Cystadenocarcinoma, Serous - genetics</subject><subject>Cystadenocarcinoma, Serous - metabolism</subject><subject>Cystadenocarcinoma, Serous - pathology</subject><subject>E1AF</subject><subject>Enzyme Activation</subject><subject>Enzyme Precursors - metabolism</subject><subject>Ets</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Gene Expression</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>invasion</subject><subject>Matrix Metalloproteinases - biosynthesis</subject><subject>Matrix Metalloproteinases - genetics</subject><subject>Matrix Metalloproteinases - metabolism</subject><subject>matrix protease</subject><subject>Medical sciences</subject><subject>motility</subject><subject>Neoplasm Invasiveness</subject><subject>ovarian cancer</subject><subject>Ovarian Neoplasms - enzymology</subject><subject>Ovarian Neoplasms - metabolism</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Plasminogen Activator Inhibitor 1 - biosynthesis</subject><subject>Plasminogen Activator Inhibitor 1 - genetics</subject><subject>Plasminogen Activator Inhibitor 2 - biosynthesis</subject><subject>Plasminogen Activator Inhibitor 2 - genetics</subject><subject>Proto-Oncogene Protein c-ets-1</subject><subject>Proto-Oncogene Proteins - biosynthesis</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins c-ets</subject><subject>RNA, Messenger - biosynthesis</subject><subject>RNA, Messenger - genetics</subject><subject>Tissue Inhibitor of Metalloproteinase-1 - biosynthesis</subject><subject>Tissue Inhibitor of Metalloproteinase-1 - genetics</subject><subject>Tissue Inhibitor of Metalloproteinase-2 - biosynthesis</subject><subject>Tissue Inhibitor of Metalloproteinase-2 - genetics</subject><subject>Transcription Factors - biosynthesis</subject><subject>Transcription Factors - genetics</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>Urokinase-Type Plasminogen Activator - biosynthesis</subject><subject>Urokinase-Type Plasminogen Activator - genetics</subject><subject>Urokinase-Type Plasminogen Activator - metabolism</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcFv0zAUxi0EYmXjyhFZQtotxXYSN-GGog4mddoOY1frxXlBRqld_Nxq_SP4n3HUCk672JL9-z4_fx9jH6RYSiH0559HH5ZKCLGs26p6xRZStHWhm7p9zRZCtKJoVN1csHdEvzJVCqnesgsphS51XS3Yn_XzLiKRC56HkT9BdGFP_A5SdM_8IYaEQEgc_MDXifgNbN105I8RPNnodikLYcrHNoVI3Hl-f8ge4HkH3mLkHU4T3ziP9IV3IUacYNbwFPitPwC5A_KH_IpPDqYr9maEifD9eb9kP27Wj933YnP_7bb7uilspctUWGwljKIWfQtQa1RStVYPWuBgsRpW1dj3qLRSjR1E2WNe1KqsbL5QGRnLS3Z98t3F8HuPlMzWkc2Tgsf8fbNSZVsJITO4PIE2BqKIo9lFt4V4NFKYuQAzF2DmAsxcQBZ8PDvv-y0O__Fz4hn4dAaALExjDtI6-setWl2pMlPNicKcwsFhNGQd5kAHF9EmMwT30gR_AYBbpIw</recordid><startdate>20001101</startdate><enddate>20001101</enddate><creator>Nishikawa, Akira</creator><creator>Iwasaki, Masahiro</creator><creator>Akutagawa, Noriyuki</creator><creator>Manase, Kengo</creator><creator>Yamashita, Satoko</creator><creator>Endo, Toshiaki</creator><creator>Kudo, Ryuichi</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001101</creationdate><title>Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential</title><author>Nishikawa, Akira ; Iwasaki, Masahiro ; Akutagawa, Noriyuki ; Manase, Kengo ; Yamashita, Satoko ; Endo, Toshiaki ; Kudo, Ryuichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-ce91af050b9aa56e2129c6d60edce4d74fbbe26228cd03bed032734c74f2edcf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenovirus E1A Proteins - biosynthesis</topic><topic>Adenovirus E1A Proteins - genetics</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Endometrioid - enzymology</topic><topic>Carcinoma, Endometrioid - genetics</topic><topic>Carcinoma, Endometrioid - pathology</topic><topic>Cell Division - physiology</topic><topic>Cell Movement - physiology</topic><topic>Cystadenocarcinoma, Serous - genetics</topic><topic>Cystadenocarcinoma, Serous - metabolism</topic><topic>Cystadenocarcinoma, Serous - pathology</topic><topic>E1AF</topic><topic>Enzyme Activation</topic><topic>Enzyme Precursors - metabolism</topic><topic>Ets</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Gene Expression</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>invasion</topic><topic>Matrix Metalloproteinases - biosynthesis</topic><topic>Matrix Metalloproteinases - genetics</topic><topic>Matrix Metalloproteinases - metabolism</topic><topic>matrix protease</topic><topic>Medical sciences</topic><topic>motility</topic><topic>Neoplasm Invasiveness</topic><topic>ovarian cancer</topic><topic>Ovarian Neoplasms - enzymology</topic><topic>Ovarian Neoplasms - metabolism</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Plasminogen Activator Inhibitor 1 - biosynthesis</topic><topic>Plasminogen Activator Inhibitor 1 - genetics</topic><topic>Plasminogen Activator Inhibitor 2 - biosynthesis</topic><topic>Plasminogen Activator Inhibitor 2 - genetics</topic><topic>Proto-Oncogene Protein c-ets-1</topic><topic>Proto-Oncogene Proteins - biosynthesis</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins c-ets</topic><topic>RNA, Messenger - biosynthesis</topic><topic>RNA, Messenger - genetics</topic><topic>Tissue Inhibitor of Metalloproteinase-1 - biosynthesis</topic><topic>Tissue Inhibitor of Metalloproteinase-1 - genetics</topic><topic>Tissue Inhibitor of Metalloproteinase-2 - biosynthesis</topic><topic>Tissue Inhibitor of Metalloproteinase-2 - genetics</topic><topic>Transcription Factors - biosynthesis</topic><topic>Transcription Factors - genetics</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>Urokinase-Type Plasminogen Activator - biosynthesis</topic><topic>Urokinase-Type Plasminogen Activator - genetics</topic><topic>Urokinase-Type Plasminogen Activator - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nishikawa, Akira</creatorcontrib><creatorcontrib>Iwasaki, Masahiro</creatorcontrib><creatorcontrib>Akutagawa, Noriyuki</creatorcontrib><creatorcontrib>Manase, Kengo</creatorcontrib><creatorcontrib>Yamashita, Satoko</creatorcontrib><creatorcontrib>Endo, Toshiaki</creatorcontrib><creatorcontrib>Kudo, Ryuichi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nishikawa, Akira</au><au>Iwasaki, Masahiro</au><au>Akutagawa, Noriyuki</au><au>Manase, Kengo</au><au>Yamashita, Satoko</au><au>Endo, Toshiaki</au><au>Kudo, Ryuichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>2000-11-01</date><risdate>2000</risdate><volume>79</volume><issue>2</issue><spage>256</spage><epage>263</epage><pages>256-263</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><coden>GYNOA3</coden><abstract>Objectives. The aim of our study was to determine the important molecules responsible for the invasive activity of ovarian cancer cells. Methods. We compared the biological characteristics, that is, growth rate, motility, and invasive activity, of five ovarian cancer cell lines with the gene expression of various matrix proteases (matrix metalloproteinase-1 [MMP-1], MMP-2, MMP-9, membrane-type MMP type 1 [MT1-MMP], MT2-MMP, MT3-MMP, urokinase plasminogen activator [uPA]), their inhibitors (tissue inhibitor of metalloproteinase type 1 [TIMP-1], TIMP-2, plasminogen activator inhibitor type 1, [PAI-1], and PAI-2), and the potential transcriptional regulators E1AF and Ets-1. Results. There was no clear correlation in the growth rate, motility, and invasion, suggesting that there are independent properties for malignant potential in ovarian cancer cells. However, HTBOA, a poorly differentiated cancer cell line, exhibited highly invasive activity, rapid growth, and increased motility. This cell line also expressed both Ets transcriptional factors, E1AF and Ets-1, and many matrix-degrading enzymes. Three cell lines that expressed E1AF showed rapid cell growth. The highly invasive cell lines, HTBOA and HTOA (well-differentiated serous cystadenocarcinoma), produced either MMP-2 or MMP-1, and both cell lines expressed MT1-MMP and uPA. Furthermore, the active forms of pro-MMP-2 and pro-MMP-1 were detected in HTBOA and HTOA by zymography. Conclusion. We conclude that activated MMP-2 and MMP-1 are important in the invasive activity of these ovarian cancer cells.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>11063654</pmid><doi>10.1006/gyno.2000.5944</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-8258
ispartof Gynecologic oncology, 2000-11, Vol.79 (2), p.256-263
issn 0090-8258
1095-6859
language eng
recordid cdi_proquest_miscellaneous_72394001
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adenocarcinoma - genetics
Adenocarcinoma - metabolism
Adenocarcinoma - pathology
Adenovirus E1A Proteins - biosynthesis
Adenovirus E1A Proteins - genetics
Biological and medical sciences
Carcinoma, Endometrioid - enzymology
Carcinoma, Endometrioid - genetics
Carcinoma, Endometrioid - pathology
Cell Division - physiology
Cell Movement - physiology
Cystadenocarcinoma, Serous - genetics
Cystadenocarcinoma, Serous - metabolism
Cystadenocarcinoma, Serous - pathology
E1AF
Enzyme Activation
Enzyme Precursors - metabolism
Ets
Female
Female genital diseases
Gene Expression
Gynecology. Andrology. Obstetrics
Humans
invasion
Matrix Metalloproteinases - biosynthesis
Matrix Metalloproteinases - genetics
Matrix Metalloproteinases - metabolism
matrix protease
Medical sciences
motility
Neoplasm Invasiveness
ovarian cancer
Ovarian Neoplasms - enzymology
Ovarian Neoplasms - metabolism
Ovarian Neoplasms - pathology
Plasminogen Activator Inhibitor 1 - biosynthesis
Plasminogen Activator Inhibitor 1 - genetics
Plasminogen Activator Inhibitor 2 - biosynthesis
Plasminogen Activator Inhibitor 2 - genetics
Proto-Oncogene Protein c-ets-1
Proto-Oncogene Proteins - biosynthesis
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins c-ets
RNA, Messenger - biosynthesis
RNA, Messenger - genetics
Tissue Inhibitor of Metalloproteinase-1 - biosynthesis
Tissue Inhibitor of Metalloproteinase-1 - genetics
Tissue Inhibitor of Metalloproteinase-2 - biosynthesis
Tissue Inhibitor of Metalloproteinase-2 - genetics
Transcription Factors - biosynthesis
Transcription Factors - genetics
Tumor Cells, Cultured
Tumors
Urokinase-Type Plasminogen Activator - biosynthesis
Urokinase-Type Plasminogen Activator - genetics
Urokinase-Type Plasminogen Activator - metabolism
title Expression of Various Matrix Proteases and Ets Family Transcriptional Factors in Ovarian Cancer Cell Lines: Correlation to Invasive Potential
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T05%3A22%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20Various%20Matrix%20Proteases%20and%20Ets%20Family%20Transcriptional%20Factors%20in%20Ovarian%20Cancer%20Cell%20Lines:%20Correlation%20to%20Invasive%20Potential&rft.jtitle=Gynecologic%20oncology&rft.au=Nishikawa,%20Akira&rft.date=2000-11-01&rft.volume=79&rft.issue=2&rft.spage=256&rft.epage=263&rft.pages=256-263&rft.issn=0090-8258&rft.eissn=1095-6859&rft.coden=GYNOA3&rft_id=info:doi/10.1006/gyno.2000.5944&rft_dat=%3Cproquest_cross%3E72394001%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72394001&rft_id=info:pmid/11063654&rft_els_id=S0090825800959444&rfr_iscdi=true